Home › Companies › ADAPTIVE BIOTECHNOLOGIES CORP. › 2024-2025

ADAPTIVE BIOTECHNOLOGIES CORP. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated October 25, 2026.

  • 7Reported items
  • 238Asset managers
  • 872Fund votes
  • June 10, 2025Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from ADAPTIVE BIOTECHNOLOGIES CORP. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ADAPTIVE BIOTECHNOLOGIES CORP. in the interactive database Compare manager voting policies

How asset managers voted at the ADAPTIVE BIOTECHNOLOGIES CORP. 2024-2025 meeting

Each item below shows how the 238 asset managers that disclosed a ADAPTIVE BIOTECHNOLOGIES CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ADAPTIVE BIOTECHNOLOGIES CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies…: Chad Robins

No official resultsDIRECTOR ELECTIONS

Combines 5 wordings of this item as funds reported it.

78% of fund votes cast · no official result

FORWITHHOLD
Details: description as filed, votes by 69 asset managers

Description as filed by funds: To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders: Chad Robins

The 69 asset managers below reported 37,164,263 for, 10,568,153 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 37,164,263WITHHOLD: 10,568,153
Largest asset managers voting on “To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corpora” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard10,956,3860 00For
ARK ETF Trust7,553,9210 00For
BlackRock5,227,4590 00For
Columbia Threadneedle3,403,6100 00For
Fidelity2,563,4970 0274,786Mixed
Aberdeen00 01,640,384Withhold
MFS1,528,5960 00For
Voya00 01,347,968Withhold
TIAA1,265,8150 00For
ALGER FUNDS00 01,238,622Withhold
Bridge Builder Trust54,5410 0895,060Mixed
Charles Schwab926,8400 00For
Aristotle Funds Series Trust00 0792,975Withhold
Goldman Sachs745,8530 00For
First Trust00 0724,091Withhold
Victory Capital00 0689,287Withhold
OPTIMUM FUND TRUST199,7130 0291,676Mixed
JPMorgan456,8600 00For
Dimensional00 0450,386Withhold
Equitable314,0000 0130,769Mixed
Allspring00 0321,556Withhold
Calamos301,6590 00For
Lord Abbett00 0291,538Withhold
Pacific Life258,0840 00For
Lincoln Financial148,9970 080,519Mixed

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

2. To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy…

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 6 wordings of this item as funds reported it.

99% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: description as filed, votes by 232 asset managers

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement;

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 67 asset managers voting on “To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in ” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard10,956,3860 00For
ARK ETF Trust7,553,9210 00For
BlackRock5,227,4590 00For
Columbia Threadneedle3,403,6100 00For
Fidelity2,838,2830 00For
Aberdeen1,640,3840 00For
MFS1,528,5960 00For
Voya1,347,9680 00For
TIAA1,265,8150 00For
ALGER FUNDS1,238,6220 00For
Bridge Builder Trust949,6010 00For
Charles Schwab926,8400 00For
Aristotle Funds Series Trust792,9750 00For
Goldman Sachs745,8530 00For
First Trust724,0910 00For
Victory Capital689,2870 00For
OPTIMUM FUND TRUST491,3890 00For
JPMorgan456,8600 00For
Dimensional450,3860 00For
Equitable444,7690 00For
Allspring321,5560 00For
Calamos301,6590 00For
Lord Abbett291,5380 00For
Pacific Life258,0840 00For
Lincoln Financial229,5160 00For

Fund voting reports, all 67 managers: 47,395,632 for, 67,900 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 187 asset managers voting on “To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in ” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
VIKING GLOBAL INVESTORS LP29,993,7080 00For
Rubric Capital Management LP8,896,0740 00For
Nikko Asset Management Co., Ltd.5,757,3710 00For
BlackRock4,730,6460 00For
GEODE CAPITAL MANAGEMENT, LLC2,831,4560 00For
Iron Triangle Partners LP2,093,8970 00For
State Street2,077,8310 00For
Blue Water Life Science Advisors, LP2,002,8390 00For
Voya1,940,3850 00For
Victory Capital1,839,7470 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1,728,9540 00For
DRIEHAUS CAPITAL MANAGEMENT LLC1,716,7580 00For
Aberdeen1,640,3840 00For
BRAIDWELL LP1,585,5670 00For
FRED ALGER MANAGEMENT, LLC1,577,0550 00For
Nuveen1,284,1290 00For
Aristotle Atlantic Partners, LLC1,269,7540 00For
Charles Schwab927,4450 00For
LORD, ABBETT & CO. LLC864,2720 00For
Northern Trust777,2130 00For
PRINCIPAL GLOBAL INVESTORS627,1730 00For
KENNEDY CAPITAL MANAGEMENT LLC599,5510 00For
Clearline Capital LP586,3800 00For
Polar Asset Management Partners Inc.481,7930 00For
Prudential/PGIM15,000451,310 00Against

Institutional-manager reports, all 187 managers: 83,803,651 for, 1,405,323 against, 76,365 withheld, 77 not voted. Showing the 25 largest; see all in the interactive database.

3. 14A Executive Compensation To approve, on a non-binding advisory basis, the compensation of our named executive…

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: description as filed, votes by 3 asset managers

Description as filed by funds: 14A Executive Compensation To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 2 asset managers voting on “14A Executive Compensation To approve, on a non-binding advisory basis, the compensation of our named executiv” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
RBB FUND, INC.132,9090 00For
Dunham Funds116,8700 00For

Fund voting reports, all 2 managers: 249,779 for.

Institutional-manager reports: 1 asset manager voting on “14A Executive Compensation To approve, on a non-binding advisory basis, the compensation of our named executiv” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Pier Capital, LLC671,4040 00For

Institutional-manager reports, all 1 managers: 671,404 for.

4. Advisory Vote to Ratify Named Executive Officers' Compensation

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 3 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 1 asset manager voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
FORUM FUNDS II19,1050 00For

Fund voting reports, all 1 managers: 19,105 for.

Institutional-manager reports: 2 asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
JPMorgan948,2460 00For
ESSEX INVESTMENT MANAGEMENT CO LLC267,7960 00For

Institutional-manager reports, all 2 managers: 1,216,042 for.

5. 14A Executive Compensation

No official resultsSECTION 14A SAY-ON-PAY VOTES

83% of fund votes cast · no official result

FORAGAINST
Details: votes by 2 asset managers

The 2 asset managers below reported 500 for, 100 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 500AGAINST: 100
Largest asset managers voting on “14A Executive Compensation” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Baker Avenue Asset Management, LP5000 00For
Focus Partners Wealth0100 00Against

6. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending…

No official resultsAUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 67 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025; and

The 67 asset managers below reported 47,463,532 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 47,463,532
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the ye” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard10,956,3860 00For
ARK ETF Trust7,553,9210 00For
BlackRock5,227,4590 00For
Columbia Threadneedle3,403,6100 00For
Fidelity2,838,2830 00For
Aberdeen1,640,3840 00For
MFS1,528,5960 00For
Voya1,347,9680 00For
TIAA1,265,8150 00For
ALGER FUNDS1,238,6220 00For
Bridge Builder Trust949,6010 00For
Charles Schwab926,8400 00For
Aristotle Funds Series Trust792,9750 00For
Goldman Sachs745,8530 00For
First Trust724,0910 00For
Victory Capital689,2870 00For
OPTIMUM FUND TRUST491,3890 00For
JPMorgan456,8600 00For
Dimensional450,3860 00For
Equitable444,7690 00For
Allspring321,5560 00For
Calamos301,6590 00For
Lord Abbett291,5380 00For
Pacific Life258,0840 00For
Lincoln Financial229,5160 00For

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

7. Ratify Appointment of Independent Auditors To ratify the appointment of Ernst & Young LLP as our independent registered…

No official resultsAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 2 asset managers

Description as filed by funds: Ratify Appointment of Independent Auditors To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025.

The 2 asset managers below reported 249,779 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 249,779
Largest asset managers voting on “Ratify Appointment of Independent Auditors To ratify the appointment of Ernst & Young LLP as our independent r” at ADAPTIVE BIOTECHNOLOGIES CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
RBB FUND, INC.132,9090 00For
Dunham Funds116,8700 00For

Largest ADAPTIVE BIOTECHNOLOGIES CORP. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 151,916,722 shares outstanding at the time of that meeting.

Fund voting reports: top ADAPTIVE BIOTECHNOLOGIES CORP. shareholders by shares voted on “To elect one Class III director nominee to serve on the board of directors of Adaptive…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 7.21%
2ARK ETF Trust 4.97%
3BlackRock 3.44%
4Columbia Threadneedle 2.24%
5Fidelity 1.87%
6Aberdeen 1.08%
7MFS 1.01%
8Voya 0.89%
9TIAA 0.83%
10ALGER FUNDS 0.82%
Institutional-manager reports: top ADAPTIVE BIOTECHNOLOGIES CORP. shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation of our named executive officers…”, 2024-2025
#Asset manager % of shares outstanding
1VIKING GLOBAL INVESTORS LP 19.74%
2Rubric Capital Management LP 5.86%
3Nikko Asset Management Co., Ltd. 3.79%
4BlackRock 3.11%
5GEODE CAPITAL MANAGEMENT, LLC 1.86%
6Iron Triangle Partners LP 1.38%
7State Street 1.37%
8Blue Water Life Science Advisors, LP 1.32%
9Voya 1.28%
10Victory Capital 1.21%

Reported ADAPTIVE BIOTECHNOLOGIES CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

ADAPTIVE BIOTECHNOLOGIES CORP. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
VIKING GLOBAL INVESTORS LP 19.74% 13G
Viking Global Entities 19.74% DEF14A
Rubric Capital Management LP . 9.48% DEF14A
BlackRock 8.05% 13F
Vanguard Group 7.34% 13F
Nikko Asset Management Americas, Inc. 4.50% 13G
ARK Investment Management LLC 2.90% 13G
Chad Robins 2.36% DEF14A
Millennium Management 1.97% 13F
Geode Capital 1.83% 13F

Percentages above are of 151,916,722 shares outstanding, as reported by ADAPTIVE BIOTECHNOLOGIES CORP. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ADAPTIVE BIOTECHNOLOGIES CORP.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At ADAPTIVE BIOTECHNOLOGIES CORP.'s shareholder meeting held June 10, 2025, in the 2024-2025 proxy season, 238 asset managers reported how they voted in their SEC Form N-PX filings, covering 872 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, on a non-binding advisory basis, the compensation of our named executive officers… — the reporting funds and managers cast 99% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

ADAPTIVE BIOTECHNOLOGIES CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.